Silverarc Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Hold
2023
Q4
Sell
2023
Q3
$8.71M Buy
2023
Q2
$3.3M Buy
2022
Q4
Sell
2022
Q3
$714K Sell
2022
Q2
$2.44M Sell
2022
Q1
$3.79K Sell
2021
Q4
$8.91M Buy
2021
Q3
$8.13M Buy
2021
Q2
$6.1K Buy
2021
Q1
$857K Sell
2020
Q4
$4.39M Buy